Heterotopic Ossification –Insights from Rare Genetic Disease

ACKNOWLEDGING PREMIER
If you have received a PREMIER pilot or core usage grant, use one of our cores, or form a collaboration at one of our events that leads to a publication, please acknowledge PREMIER in related publications and presentations.  We suggest stating:

"Our Study was funded (or supported) by PREMIER, a NIH/NIAMS P30 Center for the Advancement of Precision Medicine in Rheumatology at UCSF (P30AR070155​)."